Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4.9 nM), which disables triple-negative breast cancer (TNBC) cells
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
2 mg | In stock | $ 74.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 198.00 | |
25 mg | In stock | $ 409.00 | |
50 mg | In stock | $ 595.00 | |
100 mg | In stock | $ 866.00 | |
500 mg | In stock | $ 1,770.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 133.00 |
Description | SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4.9 nM), which disables triple-negative breast cancer (TNBC) cells |
Targets&IC50 | CDK12:98 nM (Kd), CDK12:99 nM, CDK13:4.9 nM (Kd) |
Molecular Weight | 499.36 |
Formula | C21H20Cl2N10O |
CAS No. | 2387704-62-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (10.01 mM), ultrasonic and warming and heat to 60°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SR-4835 2387704-62-1 Apoptosis Cell Cycle/Checkpoint CDK Cyclin dependent kinase inhibit SR 4835 SR4835 Inhibitor inhibitor